This inventor holds 1 USPTO granted patent. Top assignee: Korea Institute of Science and Technology. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Batsuren Dulamjav: Innovator in Cancer Treatment
Introduction
Batsuren Dulamjav is a notable inventor based in Ulaanbaatar, Mongolia. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. His innovative work focuses on the development of a unique pharmaceutical composition that utilizes daurinol, a compound derived from a medicinal plant native to Mongolia.
Latest Patents
Batsuren Dulamjav holds a patent for a pharmaceutical composition containing daurinol for the prevention and treatment of cancers. This invention relates to a formulation that comprises daurinol as an active ingredient. Daurinol has the ability to selectively block the S phase of the cancer cell cycle, disrupting the cycle and inducing apoptosis in a stepwise manner. This mechanism results in a significant anticancer effect, making daurinol a promising candidate for cancer therapy and prevention.
Career Highlights
Batsuren Dulamjav is affiliated with the Korea Institute of Science and Technology, where he conducts research and development in the field of cancer biology. His work has positioned him as a key figure in the exploration of novel treatments for cancer, particularly through the use of natural compounds.
Collaborations
He collaborates with esteemed colleagues such as Chu Won Nho and Kyung Su Kang, contributing to a dynamic research environment focused on innovative cancer therapies.
Conclusion
Batsuren Dulamjav's contributions to cancer treatment through his patent on daurinol highlight the potential of natural compounds in pharmaceutical applications. His work not only advances scientific knowledge but also offers hope for effective cancer therapies in the future.